InvestorsHub Logo
Followers 0
Posts 87
Boards Moderated 0
Alias Born 03/10/2013

Re: None

Monday, 11/19/2018 8:33:13 AM

Monday, November 19, 2018 8:33:13 AM

Post# of 427376
At the Jefferies conference JT said that even the most enthusiastic doctors are not going to call all of their patients in for immediate special consultations to switch them over to Vascepa. They will wait until the next regularly scheduled 6 month or annual appointment to discuss it with them. So it will take a full year to get all their patients started.

He is also still guiding toward FDA approval for the expanded indication to be at the end of 2019 and full insurance coverage to follow after that. I believe marketing replied to a question from someone here that they will not change their advertising to target the expanded population until after FDA approval.

Having said that, the market should start valuing the stock based on the billions they know will be made in 2-5 years, just like they are giving AMZN a PE of 92 now. Everyone just assumes Bezos really is Dr. Evil and will take over the world.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News